Deep learning and machine learning in CT-based COPD diagnosis: Systematic review and meta-analysis
Qian Wu,
No information about this author
Hui Guo,
No information about this author
Ruihan Li
No information about this author
et al.
International Journal of Medical Informatics,
Journal Year:
2025,
Volume and Issue:
196, P. 105812 - 105812
Published: Jan. 30, 2025
Language: Английский
Early Diagnosis of Pneumonia and Chronic Obstructive Pulmonary Disease with a Smart Stethoscope with Cloud Server-Embedded Machine Learning in the Post-COVID-19 Era
Direk Sueaseenak,
No information about this author
Peeravit Boonsat,
No information about this author
Suchada Tantisatirapong
No information about this author
et al.
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(2), P. 354 - 354
Published: Feb. 4, 2025
Background/Objectives:
Respiratory
diseases
are
common
and
result
in
high
mortality,
especially
the
elderly,
with
pneumonia
chronic
obstructive
pulmonary
disease
(COPD).
Auscultation
of
lung
sounds
using
a
stethoscope
is
crucial
method
for
diagnosis,
but
it
may
require
specialized
training
involvement
pulmonologists.
This
study
aims
to
assist
medical
professionals
who
non-pulmonologist
doctors
early
screening
COPD
by
developing
smart
cloud
server-embedded
machine
learning
diagnose
sounds.
Methods:
The
was
developed
Micro-Electro-Mechanical
system
(MEMS)
microphone
record
mobile
application
then
send
them
wirelessly
server
real-time
classification.
Results:
model
classifies
into
four
categories:
normal,
pneumonia,
COPD,
other
respiratory
diseases.
It
achieved
an
accuracy
89%,
sensitivity
89.75%,
specificity
95%.
In
addition,
testing
healthy
volunteers
yielded
80%
distinguishing
normal
diseased
lungs.
Moreover,
performance
comparison
between
two
commercial
auscultation
stethoscopes
showed
comparable
sound
quality
loudness
results.
Conclusions:
holds
great
promise
improving
healthcare
delivery
post-COVID-19
era,
offering
probability
most
likely
conditions
diagnosis
Its
user-friendly
design
capabilities
provide
valuable
resource
delivering
timely,
evidence-based
diagnoses,
aiding
treatment
decisions,
paving
way
more
accessible
care.
Language: Английский
Assessing the Impact of New Technologies on Managing Chronic Respiratory Diseases
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(22), P. 6913 - 6913
Published: Nov. 16, 2024
Chronic
respiratory
diseases
(CRDs),
including
asthma
and
chronic
obstructive
pulmonary
disease
(COPD),
represent
significant
global
health
challenges,
contributing
to
substantial
morbidity
mortality.
As
the
prevalence
of
CRDs
continues
rise,
particularly
in
low-income
countries,
there
is
a
pressing
need
for
more
efficient
personalized
approaches
diagnosis
treatment.
This
article
explores
impact
emerging
technologies,
artificial
intelligence
(AI),
on
management
CRDs.
AI
applications,
machine
learning
(ML),
deep
(DL),
large
language
models
(LLMs),
are
transforming
landscape
CRD
care,
enabling
earlier
diagnosis,
treatment,
enhanced
remote
patient
monitoring.
The
integration
with
telehealth
wearable
technologies
further
supports
proactive
interventions
improved
outcomes.
However,
challenges
remain,
issues
related
data
quality,
algorithmic
bias,
ethical
concerns
such
as
privacy
transparency.
paper
evaluates
effectiveness,
accessibility,
implications
AI-driven
tools
management,
offering
insights
into
their
potential
shape
future
healthcare.
advanced
managing
like
COPD
holds
enhancing
early
monitoring,
though
remain
regarding
considerations,
regulatory
oversight.
Language: Английский
From prevention to management: exploring AI’s role in metabolic syndrome management: a comprehensive review
Udit Choubey,
No information about this author
Vashishta Avadhani Upadrasta,
No information about this author
Inder P. Kaur
No information about this author
et al.
The Egyptian Journal of Internal Medicine,
Journal Year:
2024,
Volume and Issue:
36(1)
Published: Nov. 19, 2024
Abstract
Background
This
review
aims
to
comprehensively
explore
the
integration
of
artificial
intelligence
(AI)
in
prevention,
diagnosis,
and
treatment
metabolic
syndrome
(MetS).
MetS
is
characterized
by
a
cluster
conditions,
posing
growing
public
health
threat
globally.
Recognizing
limitations
traditional
management
approaches,
we
emphasize
potential
AI
transforming
MetS,
focusing
on
recent
advancements
applications
risk
prediction
diagnosis.
Body
conclusion.
The
medicine
expanding,
particularly
managing
involving
conditions
like
hypertension
dyslipidemia.
Diagnosis
challenges
stem
from
addressing
multiple
simultaneously.
tools
prove
essential
monitoring
indices
such
as
blood
pressure
glucose,
identifying
trends
for
adjustments.
Lifestyle
modifications
are
crucial,
can
facilitate
these
changes
through
user-friendly
interfaces
positive
reinforcement.
Standardization
successful
implementation
medical
practices
necessary
revolutionizing
management,
requiring
focused
future
research
efforts.
Language: Английский